ADD'L CLAIMED INTENDED USE FOR IDEIA(TM) CHLAMYDIA— 510(k) K901972

Substantially Equivalent

Novo Nordisk Diagnostics, Ltd.

FDA 510(k) clearance K901972 for ADD'L CLAIMED INTENDED USE FOR IDEIA(TM) CHLAMYDIA, Substantially Equivalent on 1990-09-05. Applicant: Novo Nordisk Diagnostics, Ltd..

Clearance details

Applicant: Novo Nordisk Diagnostics, Ltd.
Product code: Code LJC
Advisory panel: Microbiology
Date received: 1990-05-01
Decision date: 1990-09-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cambridge Cb4 4ws England, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.